The International Consortium on Anti-Virals (ICAV) is a not-for-profit drug development organization dedicated to the discovery and development of anti-viral therapies for neglected and emerging diseases.

ICAV’s goal is to deliver one drug to market every five years that is affordable, effective, and accessible to all patients in need.

Link to ICAV's home page